临床普外科电子杂志 ›› 2025, Vol. 13 ›› Issue (4): 71-.

• • 上一篇    下一篇

全身麻醉复合罗哌卡因腹横肌神经阻滞在结直肠癌根治术中的应用

  

  1. 盐城市建湖县人民医院 麻醉科,江苏 盐城 224700
  • 出版日期:2025-10-01 发布日期:2026-01-30

Application of general anesthesia combined with ropivacaine transversus abdominis nerve block in radical resection of colorectal cancer

  1. Anesthesiology Department of People's Hospital of Jianhu County in Yancheng City, Jiangsu Yancheng 224700, China
  • Online:2025-10-01 Published:2026-01-30

摘要:

目的 观察全身麻醉复合罗哌卡因腹横肌神经阻滞在结直肠癌根治术中的应用效果。方法 本研究为回顾性分析,选取 2022 年 3 月至 2024 年 12 月盐城市建湖县人民医院收治的结直肠癌根治术患者68 例,依据麻醉方式差异划分为对照组与研究组各 34 例。对照组采用全身麻醉,研究组给予全身麻醉 + 罗哌卡因腹横肌神经阻滞,对比两组患者不同时间点的麻醉效果、疼痛情况,以及药物使用量和不良反应发生情况。结果 麻醉诱导前(T0),两组患者的心率及平均动脉压、肾上腺素及去甲肾上腺素水平无显著差异(P > 0.05)。T1 ~ T3 时,研究组的心率及平均动脉压、肾上腺素及去甲肾上腺素水平均低于对照组,差异均有显著性(P < 0.001)。术后 1h、6h、12h、24h,研究组患者的视觉模拟评分法评分均低于对照组,差异均有显著性(P < 0.01)。两组患者的苏醒时间、拔管时间及恢复自主呼吸时间比较无显著差异(P> 0.05),但研究组患者术中瑞芬太尼与丙泊酚用量少于对照组,差异有显著性(P < 0.05)。研究组患者出现恶心呕吐、呼吸抑制与尿潴留各 1 例,无术后谵妄,不良反应发生率为 8.82%(3/34),对照组患者出现恶心呕吐 5 例,呼吸抑制 2 例,尿潴留 2 例,术后谵妄,1 例,不良反应发生率为 29.41%(10/34),两组不良反应发生率比较差异显著(χ2=4.660,P=0.031)。结论 结直肠癌根治术患者应用全身麻醉复合罗哌卡因腹横肌神经阻滞,能维持较好的基础体征,减轻应激反应,同时又能减少术中麻醉药使用量,术后不良反应少、疼痛较轻。

关键词: 结直肠癌根治术, 全身麻醉, 罗哌卡因, 腹横肌神经阻滞

Abstract:

Objective To observe the application effect of general anesthesia (GA) combined with ropivacaine transversus abdominis nerve block (TANB) in radical resection of colorectal cancer. Method This study is a retrospective analysis. 68 patients with colorectal cancer undergoing radical resection in Jianhu County People's Hospital of Yancheng City from March 2022 to December 2024 were selected and divided into control group and study group, 34 cases in each group according to the difference of anesthesia methods. The control group was given general anesthesia, and the study group was given GA+ ropivacaine TANB. The anesthesia effect, pain, drug use and adverse reactions of the two groups at different time points were compared. Result Before anesthesia induction (T0), there was no significant difference in heart rate, mean arterial pressure, epinephrine and norepinephrine levels between the two groups (P > 0.05). From T1 to T3, the heart rate, mean arterial pressure, epinephrine and norepinephrine levels in the study group were lower than those in the control group, and the differences were significant (P < 0.001). At 1h, 6h, 12h and 24h after operation, the visual analogue scale scores of the study group were lower than those of the control group, and the differences were significant (P < 0.01). There was no significant difference in the recovery time, extubation time and recovery time of spontaneous breathing between the two groups (P > 0.05), but the dosage of remifentanil and propofol in the study group was less than that in the control group, and the difference was significant (P < 0.05). The study group had 1 case of nausea and vomiting, 1 case of respiratory depression and 1 case of urinary retention, no postoperative delirium, and the incidence of adverse reactions was 8.82%(3/34). The control group had 5 cases of nausea and vomiting, 2 cases of respiratory depression, 2 cases of urinary retention, and 1 case of postoperative delirium, and the incidence of adverse reactions was 29.41% (10/34). There was a significant difference in the incidence of adverse reactions between the two groups (χ2=4.660, P=0.031). Conclusion The application of GA combined with ropivacaine TANB in patients undergoing radical resection of colorectal cancer can maintain good basic signs, reduce stress reaction, reduce the use of intraoperative anesthetics, and reduce postoperative adverse reactions and pain.

Key words: Radical resection of colorectal cancer, General anesthesia, Ropivacaine, Transversus abdominis nerve block